These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10886720)
1. Trypanosoma brucei brucei infection impairs MHC class II antigen presentation capacity of macrophages. Namangala B; Brys L; Magez S; De Baetselier P; Beschin A Parasite Immunol; 2000 Jul; 22(7):361-70. PubMed ID: 10886720 [TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation. La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791 [TBL] [Abstract][Full Text] [Related]
3. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice. Shi M; Wei G; Pan W; Tabel H J Immunol; 2006 Feb; 176(3):1724-32. PubMed ID: 16424202 [TBL] [Abstract][Full Text] [Related]
4. Trypanosoma congolense infections: MHC class II-restricted immune responses mediate either protection or disease, depending on IL-10 function. Shi MQ; Wei GJ; Tabel H Parasite Immunol; 2007 Feb; 29(2):107-11. PubMed ID: 17241399 [TBL] [Abstract][Full Text] [Related]
5. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei. Sacco RE; Hagen M; Donelson JE; Lynch RG J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881 [TBL] [Abstract][Full Text] [Related]
7. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection. Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma and interleukin-10 have cross-regulatory roles in modulating the class I and class II MHC-mediated presentation of epitopes of Listeria monocytogenes by infected macrophages. Hiltbold EM; Ziegler HK J Interferon Cytokine Res; 1996 Jul; 16(7):547-54. PubMed ID: 8836921 [TBL] [Abstract][Full Text] [Related]
9. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Kovacsovics-Bankowski M; Rock KL Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570 [TBL] [Abstract][Full Text] [Related]
10. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus. Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218 [TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells. von Delwig A; Musson JA; Gray J; McKie N; Robinson JH Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564 [TBL] [Abstract][Full Text] [Related]
12. Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. Dagenais TR; Freeman BE; Demick KP; Paulnock DM; Mansfield JM J Immunol; 2009 Sep; 183(5):3344-55. PubMed ID: 19675169 [TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Buckner FS; Wipke BT; Van Voorhis WC Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608 [TBL] [Abstract][Full Text] [Related]
14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Svensson M; Pfeifer J; Stockinger B; Wick MJ Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741 [TBL] [Abstract][Full Text] [Related]
15. Secreted Toxoplasma gondii molecules interfere with expression of MHC-II in interferon gamma-activated macrophages. Leroux LP; Dasanayake D; Rommereim LM; Fox BA; Bzik DJ; Jardim A; Dzierszinski FS Int J Parasitol; 2015 Apr; 45(5):319-32. PubMed ID: 25720921 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules. Rosales-Reyes R; Garza-Villafuerte P; Vences-Vences D; Aubert DF; Aca-Teutle R; Ortiz-Navarrete VF; Bonifaz LC; Carrero-Sánchez JC; Olivos-García A; Valvano MA; Santos-Preciado JI Emerg Microbes Infect; 2020 Dec; 9(1):2000-2012. PubMed ID: 32873215 [TBL] [Abstract][Full Text] [Related]
17. Processing and major histocompatibility complex class II presentation of Legionella pneumophila antigens by infected macrophages. Neild A; Murata T; Roy CR Infect Immun; 2005 Apr; 73(4):2336-43. PubMed ID: 15784579 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. Rock KL; Clark K J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907 [TBL] [Abstract][Full Text] [Related]
19. Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II. Peppelenbosch MP; DeSmedt M; Pynaert G; van Deventer SJ; Grooten J J Immunol; 2000 Aug; 165(4):1984-91. PubMed ID: 10925281 [TBL] [Abstract][Full Text] [Related]
20. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo. Ho NI; Camps MGM; de Haas EFE; Ossendorp F Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]